The co-founder and former chief operating officer of telecommunications group Altice, Armando Pereira, has been detained for questioning in Portugal as part of a sweeping investigation into alleged corruption.
Microsoft Corp. and British regulators have held “productive” talks on potential remedies the tech giant can offer as it seeks to clear the final hurdle to its $69 billion Activision Blizzard Inc. deal, a lawyer for the UK watchdog said.
The heat wave engulfing the Mediterranean is set to intensify as another Saharan anticyclone threatens record temperatures from Italy to Greece.
Apollo Global Management Inc. is building a team focused on investment firms for the world’s biggest fortunes as the buyout giant ramps up plans to target the ultra-wealthy.
Richemont led luxury-goods stocks lower amid concerns that demand in the US and China, two of the biggest markets for the industry, is starting to sputter.
Eli Lilly & Co. said it applied for full US approval of its Alzheimer’s disease drug that’s expected to compete with Eisai Co.’s Leqembi as the US drugmaker revealed details of a final-stage trial at a conference in Amsterdam.
Microsoft Corp. and Activision Blizzard Inc. — the video-game empire it’s seeking to take over in a $69 billion deal — are edging closer to completing one of the biggest acquisitions of all time.
The UK Labour Party wants groups of officials from different government departments to tackle the long-term threat posed by states such as China — which it views as hostile to British interests — if it comes to power at the next general election.
Leaders of the European Union are seeking to reboot relations with Latin America in a competition for influence against Russia and China, but wrangling over Moscow’s invasion of Ukraine is hampering their efforts.
BridgeBio Pharma Inc. shares surged after the biotech company’s experimental drug cut deaths among patients suffering from a heart condition in a late-stage trial.
